ES2076106A1 - Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas - Google Patents

Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas

Info

Publication number
ES2076106A1
ES2076106A1 ES09301867A ES9301867A ES2076106A1 ES 2076106 A1 ES2076106 A1 ES 2076106A1 ES 09301867 A ES09301867 A ES 09301867A ES 9301867 A ES9301867 A ES 9301867A ES 2076106 A1 ES2076106 A1 ES 2076106A1
Authority
ES
Spain
Prior art keywords
oxindol
carboxamides
substituted
pharmaceutical compositions
compositions based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301867A
Other languages
English (en)
Other versions
ES2076106B1 (es
Inventor
Imran Ahmed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Priority to ES9301867A priority Critical patent/ES2076106B1/es
Publication of ES2076106A1 publication Critical patent/ES2076106A1/es
Application granted granted Critical
Publication of ES2076106B1 publication Critical patent/ES2076106B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)

Abstract

UNA PREPARACION FARMACEUTICA QUE COMPRENDA: (A) AL MENOS UN TRIGLICERIDO O PROPILEN GLICOL DIESTER O ACIDOS GRASOS DE ACEITE DE NUEZ DE COCO FRACCIONADO; Y (B) AL MENOS UN COMPUESTO DE FORMULA I, DONDE R1, R2 Y R3 SON CADA UNO DE ELLOS INDEPENDIENTEMENTE HIDROGENO, FLUOR, BROMO O CLORO O SUS SALES FARMACEUTICAMENTE ACEPTABLES.
ES9301867A 1993-08-26 1993-08-26 Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas Expired - Lifetime ES2076106B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301867A ES2076106B1 (es) 1993-08-26 1993-08-26 Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301867A ES2076106B1 (es) 1993-08-26 1993-08-26 Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas

Publications (2)

Publication Number Publication Date
ES2076106A1 true ES2076106A1 (es) 1995-10-16
ES2076106B1 ES2076106B1 (es) 1996-06-16

Family

ID=8282940

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301867A Expired - Lifetime ES2076106B1 (es) 1993-08-26 1993-08-26 Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas

Country Status (1)

Country Link
ES (1) ES2076106B1 (es)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156603A2 (en) * 1984-03-19 1985-10-02 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
EP0393936A1 (en) * 1989-04-18 1990-10-24 Pfizer Inc. 3-substituted-2-oxindole derivatives as antiinflammatory agents
EP0448253A2 (en) * 1990-03-19 1991-09-25 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
WO1993013758A1 (en) * 1992-01-13 1993-07-22 Pfizer Inc. Preparation of tablets of increased strength
WO1994007488A1 (en) * 1992-10-07 1994-04-14 Pfizer Inc. 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156603A2 (en) * 1984-03-19 1985-10-02 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
EP0393936A1 (en) * 1989-04-18 1990-10-24 Pfizer Inc. 3-substituted-2-oxindole derivatives as antiinflammatory agents
EP0448253A2 (en) * 1990-03-19 1991-09-25 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
WO1993013758A1 (en) * 1992-01-13 1993-07-22 Pfizer Inc. Preparation of tablets of increased strength
WO1994007488A1 (en) * 1992-10-07 1994-04-14 Pfizer Inc. 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
ES2076106B1 (es) 1996-06-16

Similar Documents

Publication Publication Date Title
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69426904D1 (de) Phosphonat-Nukleotid Ester-Derivate
ATE179173T1 (de) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy 1,3-propandiol-derivate
SE9504661D0 (sv) New compounds
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
DK0857718T3 (da) Endothelinantagonist
DK0641325T3 (da) Inhibitorer af retroviral protease
CH692199A8 (fr) Composes pyridiques et compositions pharmaceutique
DK0393936T3 (da) 3-substituerede 2-oxindolderivater som antiinflammatoriske midler
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE69935873D1 (de) 2-Methyl-thieno-benzodiazepin Formulierung
NO163331C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 6,7-disubstituerte 1-cyklopropyl-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyrer.
ATE172985T1 (de) Sulfonamidaminomethylenderivate als immunsuppressiva
ES2051961T3 (es) Composiciones orales.
MY109680A (en) 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions.
ES2182090T3 (es) Nuevos derivados de pirrol.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SE9504662D0 (sv) New compounds
ES2130548T3 (es) Nuevos derivados alquil-amino-indanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2138211T3 (es) N-hidroxiureas como agentes antiinflamatorios.
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
ES2077473T3 (es) Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2076106B1 (es) Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas
ES2164168T3 (es) Antagonistas de receptores de fibrinogeno que tienen residuos de beta-aminoacido sustituidos y composiciones farmaceuticas que comprenden los mismos.
ES2111297T3 (es) Nuevos esteres de acidos carboxilicos de 2-amino-7-(1,3-dihidroxi-2-propoximetil)purina, su preparacion asi como su empleo.